Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Pragmatic trial to define the magnitude and the predictive factors of the response to omalizumab and mepolizumab in adult patients with severe refractory asthma and eligible to both therapies.
Epistemonikos ID: 3e2973e5481cdf827fbbbf98babba6d9e78a3f3a
First added on: May 21, 2024